Transforming Endovascular Aortic Arch Repair

With its innovative NEXUS™ Stent Graft System, Endospan has transformed treatment of life-threatening Aortic Arch Disease from a high-risk open surgery

into a minimally invasive aortic arch repair, including aneurysms and dissections.

Endospan's mission is to develop innovative products that significantly advance the treatment of aortic instability. NEXUS™ Stent Graft System is the first branched off-the-shelf endovascular system to treat Aortic Arch Disease, a greatly underserved patient population.

What are Experts Are Saying About NEXUS™ ?

Ross Milner, MD

Director, Center for Aortic Diseases;

University of Chicago Medicine

Thomas Lindsay, MD

Chief, Vascular Surgery;

Toronto General Hospital

Andrew Holden, MD

Associate Professor of Radiology;

Auckland (NZ) University

School of Medicine

Maskit St. 4  Herzlia Business Park, Herzlia, ISRAEL 46733

CAUTION: NEXUS ™ is approved for use in the European Union and may be restricted for use in other territories.

  • Facebook Social Icon

© 2019 by Endospan Ltd.   Last update September 17, 2019